Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and kt 5926

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with kt 5926 in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(kt 5926)		Trials
(kt 5926)		Recent Studies (post-2010) (kt 5926)
9,1561875524800

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwahashi, K; Kase, H; Kuroda, K; Nakanishi, S; Yamada, K1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and kt 5926

ArticleYear
KT5926, a potent and selective inhibitor of myosin light chain kinase.
    Molecular pharmacology, 1990, Volume: 37, Issue:4

    Topics: Alkaloids; Animals; Blood Platelets; Carbazoles; Chickens; Indole Alkaloids; Indoles; Kinetics; Male; Muscle, Smooth; Myosin-Light-Chain Kinase; Phosphorylation; Platelet Activating Factor; Protein Kinase C; Protein Kinase Inhibitors; Rabbits; Serotonin

1990